Almac to expand pharmaceutical facilities
Phase one of the expansion, which involves an investment of £4.5m, will provide a non-GMP formulation development facility for the development and scale-up of solid oral dose drug
AtomVie Global Radiopharma has opened a purpose-built radiopharmaceutical manufacturing facility in Hamilton, Ontario, Canada, with an investment of more than $160m.